In8bio Inc Earnings

The next earnings date for In8bio Inc has not yet been scheduled.

Analyst Estimates of In8bio Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

In8bio Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/07/2025---$-1.24-1,966.67%
05/08/2025---$-0.07-4.95%
11/13/2024---$-0.154.76%
08/09/2024---$-0.19-13.10%
05/09/2024After Market$-0.20-11.11%
03/14/2024After Market$-0.21-40.00%
11/09/2023After Market$-0.234.17%
08/10/2023After Market$-0.270.00%
05/12/2023Before Market$-0.306.25%
03/30/2023After Market$-0.37-15.63%
11/10/2022Before Market$-0.34-17.24%
08/12/2022After Market$-0.38-31.03%
05/12/2022Before Market$-0.330.00%
03/17/2022After Market$-0.2119.23%
11/10/2021After Market$-0.2510.71%
09/10/2021After Market$-0.55-37.50%
06/02/2021---$-0.82---
03/31/2021---$-0.82---
11/05/2020---$-0.14---
09/30/2020---$-0.69---
03/31/2020---$-0.59---
12/31/2019---$-0.48---
09/30/2019---$-0.48---
06/30/2019---$-0.16---
03/31/2019---$-0.16---

More About In8bio Inc

Country
USA
Full Time Employees
17

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; and INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.

In8bio Inc Earnings” Can Refer to the In8bio Inc Earnings Date

Some people say “In8bio Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my In8bio Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning In8bio Inc Stock on the Earnings Date

If you own In8bio Inc stock (INAB) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for In8bio Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading In8bio Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More In8bio Inc Earnings

You can contact us any time if you would like to ask questions about In8bio Inc earnings or anything else related to the stock market.